biote Corp. (BTMD)

NGM – Цена в реальном времени. Валюта: USD

1.79

-0.17 (-8.67%)

При закрытии: Jun 26, 2026, 4:00 PM EDT

1.79

0.00 (0.00%)

После закрытия: Jun 26, 2026, 4:31 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

biote Corp. (BTMD)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

biote Corp. (BTMD)

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

biote Corp. (BTMD) Q1 2026 Earnings Call Transcript

biote Corp. (BTMD) Q1 Earnings and Revenues Lag Estimates

Biote Reports First Quarter 2026 Financial Results

Biote Schedules First Quarter 2026 Financial Results Release and Conference Call

biote Corp. (BTMD) Q4 2025 Earnings Call Transcript

Видео

No Data

Пресс-релизы

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

Biote Reports First Quarter 2026 Financial Results

Biote Reports Fourth Quarter and Full Year 2025 Financial Results

Search stocks

biote Corp. (BTMD)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

biote Corp. (BTMD)

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

biote Corp. (BTMD) Q1 2026 Earnings Call Transcript

biote Corp. (BTMD) Q1 Earnings and Revenues Lag Estimates

Biote Reports First Quarter 2026 Financial Results

Biote Schedules First Quarter 2026 Financial Results Release and Conference Call

biote Corp. (BTMD) Q4 2025 Earnings Call Transcript

Видео

No Data

Пресс-релизы

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

Biote Reports First Quarter 2026 Financial Results

Biote Reports Fourth Quarter and Full Year 2025 Financial Results